Cargando…
MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease associated with dysfunction of pulmonary artery endothelial cells and pulmonary artery smooth muscle cells (PASMCs). To explore the potential mechanism of miR-193-3p in pulmonary arterial hypertension, human PASMCs and...
Autores principales: | Wu, Zhenhua, Geng, Jie, Qi, Yujuan, Li, Jian, Bai, Yaobang, Guo, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734527/ https://www.ncbi.nlm.nih.gov/pubmed/33354317 http://dx.doi.org/10.1177/2045894020974919 |
Ejemplares similares
-
lncRNA NEAT1 Downregulation Ameliorates the Myocardial Infarction of Mice by Regulating the miR-582-5p/F2RL2 Axis
por: Wu, Zhenhua, et al.
Publicado: (2022) -
Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
por: Nie, Xiaowei, et al.
Publicado: (2021) -
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2018) -
Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
por: Cai, Changhong, et al.
Publicado: (2019) -
Inhibiting miR-1 attenuates pulmonary arterial hypertension in rats
por: Liu, Yun, et al.
Publicado: (2021)